Trogenix (private company)

See something wrong or missing? Let us know
Offices:Edinburgh
Business model:B2B

Trogenix is a British biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour - via the Odysseus platform, which harnesses Synthetic Super-Enhancers (SSEs) to distinguish cancer cell states from healthy ones and drive selective payload delivery.

Investors: we tracked 10 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 112.83M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Trogenix

Name Criteria
Spain Ability Pharma
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France AbolerIS Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Aignostics
70%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
70%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
United Kingdom Beckley Psytech
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Spain Bigfinite
70%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 5
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Spain Inbrain Neuroelectronics
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top